Executive Summary
On January 8, 2026, an unprecedented 44 US companies filed 8-Ks under Item 5.02 for boardroom changes, spanning diverse sectors with a notable concentration in healthcare/biotech and financials, yet all lacking specifics on positions, individuals, reasons, or appointment/resignation status. Uniformly neutral sentiment and low-to-medium materiality suggest routine compensatory arrangements or administrative updates rather than disruptive turnover, minimizing immediate volatility but highlighting potential systemic reporting patterns. Cumulative impact appears benign for portfolios, but the single-day volume raises flags for underlying governance trends warranting follow-up scrutiny.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 06, 2026.
Investment Signals(4)
- ▲
Routine disclosures without disclosed controversies or key executive exits [BULLISH] - All 44 companies
- ▲
Neutral sentiment across high-volume filings indicating leadership stability [BULLISH] - Broad US equity market
- ▲
Multiple changes paired with earnings releases (Item 2.02) showing no negative context [BULLISH] - Teleflex, Frontier Group, CorMedix, Xilio, Tango, Anika, Merit Medical, Quanterix
- ▲
Absence of high-materiality flags in large caps [BULLISH] - Walmart, Illumina, LPL Financial
Risk Flags(4)
- ▼
Uniform lack of disclosure details across all filings obscures true nature of changes (appointment vs. resignation), elevating governance opacity risks
- ▼
Unusual single-day surge of 44 officer change filings signals potential hidden turnover wave or data anomaly
- ▼
Concurrent Item 2.02/7.01 disclosures without metrics in ~20% of cases introduce interpretation uncertainty
- ▼
Concentration in volatile small/mid-cap biotechs amplifies sector-specific execution risks
Opportunities(4)
- ◆
Parse full filings or follow-on 8-Ks for undisclosed positive appointments in biotechs, enabling early alpha capture
- ◆
Portfolio hedge via shorts on high-risk small caps (e.g., Nuvve, Planet 13) if patterns reveal resignations
- ◆
Long large-cap names like Walmart/Illumina post-disclosure for stability premium amid broad churn
- ◆
Sector rotation into financials (LPL, Navient) if changes signal strategic board refreshes
Sector Themes(3)
- Healthcare/biotech cluster (~25% of filings◆
Teleflex, CorMedix, Xilio, Tango, Anika, Quanterix, Illumina, CONMED, Merit) suggests routine pipeline/leadership alignment amid R&D pressures
- ◆
Financial services activity (LPL Financial, Navient, bancorps) points to regulatory or post-earnings governance tweaks
- ◆
Broad cross-sector dispersion with frequent Item 9.01 exhibits implies standardized compensatory updates, not crisis-driven
Watch List(4)
- 👁
Walmart Inc. - Retail bellwether; any C-suite implications could ripple through consumer sector
- 👁
Illumina, Inc. - Biotech leader with Reg FD disclosure; monitor for M&A or strategy shifts
- 👁
Frontier Group Holdings, Tango Therapeutics - Earnings + officer change combo; potential volatility catalysts
- 👁
Healthcare/biotech cluster (Teleflex, Xilio, Quanterix) - Watch for turnover patterns signaling sector distress or renewal
Filing Analyses(44)
08-01-2026
Enpro Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000570, Size: 139 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or quantitative data are provided in the summary. Sector is not specified.
08-01-2026
TELEFLEX INC filed a Form 8-K on January 08, 2026 (AccNo: 0000096943-26-000003, Size: 192 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also covers Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, reason, financial metrics, or quantitative data are provided.
08-01-2026
Company filed an 8-K on 2026-01-08 (AccNo: 0001140361-26-000614, Size: 215 KB) reporting an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Event Type: Officer Change. No specific details on officers, reasons, or impacts disclosed.
08-01-2026
Transcat Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001206774-26-000020, Size: 285 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Frontier Group Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007030, Size: 170 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or share counts are mentioned.
08-01-2026
Walmart Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0000104169-26-000008, Size: 258 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Sector is not specified.
08-01-2026
Leslie's, Inc. disclosed an Item 5.02 event in an 8-K filing on January 8, 2026 (AccNo: 0001193125-26-007067, Size: 183 KB), related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
CorMedix Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002350, Size: 297 KB), reporting an Officer Change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position, reason for change, or financial metrics are disclosed in the provided filing summary. Sector not specified.
08-01-2026
Lightwave Logic, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001079973-26-000061, Size: 194 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed in the provided summary. Sector is not specified.
08-01-2026
Xilio Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007063, size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). Event dated January 08, 2026; sector not specified. No specific details on officer position, appointment/resignation, reasons, or financial metrics provided.
08-01-2026
LPL Financial Holdings Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007083, Size: 166 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, reason for change, or any quantitative data are disclosed.
08-01-2026
Nuvve Holding Corp. disclosed an officer change event via Form 8-K filed on January 08, 2026 (AccNo: 0001836875-26-000008, Size: 203 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, appointment or resignation status, reasons for change, named individuals, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
08-01-2026
USANA Health Sciences Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0000896264-26-000002, size 176 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided. Sector is not specified.
08-01-2026
Tango Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001193125-26-007086, Size: 5 MB), triggering Items 2.02 (Results of Operations and Financial Condition), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is classified as an Officer Change event. No specific details on officers, reasons for change, financial metrics, or quantitative data are disclosed in the provided filing summary.
08-01-2026
First Northwest Bancorp filed a Form 8-K on January 08, 2026 (AccNo: 0001437749-26-000851, Size: 152 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected individuals, positions, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Apple iSports Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000095, Size: 128 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, names, reasons for change, or quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Company filed Form 8-K on 2026-01-08 (AccNo: 0000944130-26-000004, Size: 185 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change with event date January 08, 2026. No specific details on position affected, individual names, reasons for change, internal/external status, compensation, or quantitative metrics are disclosed.
08-01-2026
Ambiq Micro, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007673, Size: 143 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, compensation, or board impacts are provided. Sector is not specified.
08-01-2026
TRANSUITE.ORG INC. disclosed an officer change via Form 8-K filed on January 8, 2026 (AccNo: 0001640334-26-000058, Size: 126 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data provided in the filing summary. Sector not specified.
08-01-2026
Anika Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007655, Size: 557 KB) reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or names are disclosed in the provided filing summary. Sector not specified.
08-01-2026
Alliant Energy Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000352541-26-000003, Size: 193 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or quantitative data are provided in the available information. Event type is Officer Change; sector not specified.
08-01-2026
Applied Digital Corp. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000974, Size: 371 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment or resignation status, reasons, or compensation are provided. Sector is not specified.
08-01-2026
Littelfuse Inc./DE filed an 8-K on January 8, 2026 (AccNo: 0001140361-26-000720, size 194 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reason, or compensation provided in the available information. Sector not specified.
08-01-2026
Graphic Packaging Holding Co filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-007697, Size: 132 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the officer's name, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
08-01-2026
Senmiao Technology Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002536, Size: 267 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or compensation provided.
08-01-2026
EPLUS INC filed a Form 8-K on January 08, 2026 (AccNo: 0001022408-26-000009, Size: 168 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided. Sector is not specified.
08-01-2026
MID PENN BANCORP INC disclosed an officer change via Form 8-K filed on January 08, 2026 (AccNo: 0000879635-26-000007, Size: 494 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change, reasons, or compensation are provided.
08-01-2026
Vita Coco Company, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001348, Size: 198 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, name, appointment/resignation status, reasons, or any quantitative data are disclosed in the provided filing summary.
08-01-2026
V2X, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001628280-26-001359, Size: 181 KB), disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the available information. Sector is not specified.
08-01-2026
McGraw Hill, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007781, size: 131 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details such as names, positions, reasons for change, or quantitative data are provided in the summary. Sector is not specified.
08-01-2026
MERIT MEDICAL SYSTEMS INC filed an 8-K on January 08, 2026 (AccNo: 0000856982-26-000002, Size: 292 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Event type is Officer Change from US SEC source; sector not specified. No specific details on position, person, reason, or financial metrics provided.
08-01-2026
SilverBox Corp V filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002148, size: 261 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, positions affected, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Loop Industries, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000892, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data are disclosed. Sector is not specified.
08-01-2026
Quanterix Corp filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001369, Size: 350 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.
08-01-2026
Praxis Precision Medicines, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001689548-26-000005, Size: 155 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event type is Officer Change from US SEC source. Sector not specified; no details on specific officer, position, reason, or nature of change provided.
08-01-2026
Planet 13 Holdings Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000891, Size: 150 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any compensation arrangements are provided in the filing summary. Sector is not specified.
08-01-2026
Illumina, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001110803-26-000006, Size: 185 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data provided in the filing summary. Sector not specified.
08-01-2026
CONMED Corp filed an 8-K on 2026-01-08 (AccNo: 0001174947-26-000017, Size: 284 KB) disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer change, names, positions, reasons, or quantitative data provided.
08-01-2026
SS Innovations International, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002572, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
08-01-2026
Company filed an 8-K on 2026-01-08 (AccNo: 0001316944-26-000007, Size: 361 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change, source us_sec, sector not specified. No specific details on officer name, position, appointment/resignation, reasons, or quantitative data provided.
08-01-2026
Amphenol Corp (/DE/) filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002183, Size: 205 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, internal/external status, or quantitative data such as compensation are provided in the summary. Event type is Officer Change; sector not specified.
08-01-2026
374Water Inc. filed an 8-K on January 8, 2026 (AccNo: 0001654954-26-000199, Size: 142 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, or any financial metrics are disclosed. Sector is not specified.
08-01-2026
Indaptus Therapeutics, Inc. filed an 8-K on 2026-01-08 (AccNo: 0001493152-26-001004, Size: 207 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data provided.
Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 44 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings